(Q35904008)

11 August 2017

1 reference

title

The use of gene therapy in cancer research and treatment (English)

1 reference

11 August 2017

0 references

E T Shinohara

1

1 reference

11 August 2017

B Lu

series ordinal

2

1 reference

11 August 2017

D E Hallahan

series ordinal

3

1 reference

11 August 2017

language of work or name

1 reference

1 October 2004

1 reference

Technology in Cancer Research and Treatment

11 August 2017

published in

1 reference

11 August 2017

volume

3

1 reference

11 August 2017

issue

5

1 reference

11 August 2017

page(s)

479-490

1 reference

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Gene therapy in the post-Gelsinger era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Cytochrome P450 gene-directed enzyme prodrug therapy (GDEPT) for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Variable efficiency of the thymidine kinase/ganciclovir system in human glioblastoma cell lines: implications for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Lung cancer vaccines and gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Prevention of cervical cancer with vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Therapeutic vaccines for human papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Phase I trial of antigen-specific gene therapy using a recombinant vaccinia virus encoding MUC-1 and IL-2 in MUC-1-positive patients with advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Gene therapy for lung cancer: enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Gene therapy progress and prospects: cancer gene therapy using tumour suppressor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Why did p53 gene therapy fail in ovarian cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Use of replication-conditional adenovirus as a helper system to enhance delivery of P450 prodrug-activation genes for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Evidence that replication of the antitumor adenovirus ONYX-015 is not controlled by the p53 and p14(ARF) tumor suppressor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Analyses of single-amino-acid substitution mutants of adenovirus type 5 E1B-55K protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Vascular endothelial growth factor (VEGF) in astrocytic gliomas--a prognostic factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome P450 2B1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Control of programmed cell death by the baculovirus genes p35 and iap.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Validating survivin as a cancer therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Overcoming resistance of cancer cells to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Mitochondria are selectively eliminated from eukaryotic cells after blockade of caspases during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Death and decoy receptors and p53-mediated apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Activation of stress-responsive promoters by ionizing radiation for deployment in targeted gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Ionizing radiation induces expression and binding activity of the nuclear factor kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Protein kinase C mediates x-ray inducibility of nuclear signal transducers EGR1 and JUN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Spatial and temporal control of gene therapy using ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Tumor production of angiostatin is enhanced after exposure to TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

The gamma 1(34.5) gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programed cell death in neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

MIA (melanoma inhibitory activity) promoter mediated tissue-specific suicide gene therapy of malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Survivin as a therapeutic target for radiation sensitization in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Inhibition of viral growth by antisense oligonucleotides directed against the IE110 and the UL30 mRNA of herpes simplex virus type-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Rational selection of antisense oligonucleotide sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Antisense MDM2 sensitizes prostate cancer cells to androgen deprivation, radiation, and the combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

The mdm2 proto-oncogene sensitizes human medullary thyroid carcinoma cells to ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

VEGF receptor antisense therapy inhibits angiogenesis and peritoneal dissemination of human gastric cancer in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Mechanisms of caspase activation and inhibition during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

21 January 2018

RNA interference--2001.

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

A species of small antisense RNA in posttranscriptional gene silencing in plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Ancient pathways programmed by small RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Killing the messenger: short RNAs that silence gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Effects on RNA interference in gene expression (RNAi) in cultured mammalian cells of mismatches and the introduction of chemical modifications at the 3'-ends of siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Mechanism of action of hammerhead ribozymes and their applications in vivo: rapid identification of functional genes in the post-genome era by novel hybrid ribozyme libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

U6 promoter-driven siRNAs with four uridine 3' overhangs efficiently suppress targeted gene expression in mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Suppression of Gene Expression by RNA Interference in Cultured Plant Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Use of adeno-associated viral vector for delivery of small interfering RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the nuclear factor-kappaB p65 subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300509

10.1177/153303460400300509

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference